The Global Pyrogen Testing Market was about US$1.3 billion in 2023. It is expected to grow to around US$ 2.87 billion by 2031, with a compound annual growth rate of about 11.95% during the forecast period from 2024 to 2031.

Pyrogen testing is crucial in the pharmaceutical and biotechnology industries. It ensures the safety of injectable drugs, vaccines, and medical devices by detecting fever-causing contaminants. The market is expanding due to the increase in biologics production, strict regulatory demands, the rising number of chronic diseases, and the move toward improved, animal-free testing methods. North America has the largest market share, while the Asia Pacific region is growing the fastest thanks to better healthcare infrastructure and biopharmaceutical manufacturing.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/pyrogen-testing-market?ram

United States: Key Industry Developments

✅ October 2025: Charles River Laboratories introduced advanced endotoxin testing solutions integrating AI-powered data analytics to accelerate biopharmaceutical safety assessments.

✅ September 2025: FUJIFILM Wako Chemicals launched innovative LAL test kits with improved sensitivity and rapid results, enhancing pharmaceutical quality control.

✅ August 2025: BioMérieux expanded its portfolio with new in vitro pyrogen testing platforms targeting vaccine and sterile injectable manufacturers, supporting regulatory compliance and automation.

Japan: Key Industry Developments

✅ October 2025: Eurofins Scientific strengthened testing capabilities in Japan through new laboratory openings and partnerships with local pharmaceutical companies focusing on pyrogen safety standards.

✅ September 2025: Lonza Group rolled out fast monocyte activation test (MAT) systems in Japan to offer animal-free, rapid pyrogen detection aligned with evolving global regulations.

✅ August 2025: Thermo Fisher Scientific collaborated with Japanese biotech firms to develop integrated pyrogen testing workflows aimed at increasing throughput and reducing cycle times in biologics production.

Mergers and Acquisitions (2025):

✅ Charles River Laboratories - expanded its pyrogen testing capabilities by acquiring specialized biotechnology firms focusing on animal-free testing technologies.

✅ FUJIFILM Wako Chemicals - launched innovative consumables in 2024 and strengthened its market presence through acquisitions aimed at boosting recombinant and rapid pyrogen testing solutions.

✅ Lonza Group - introduced advanced testing devices and acquired companies focused on Monocyte Activation Test (MAT) technologies, enhancing rapid, animal-free pyrogen detection.

Key Players:

=> Merck KGaA, Lonza Group, Ellab A/S, Electronics India, Charles River Laboratories, BioNordika AS, Eurofins Biolab Srl, CellMade Laboratories, and Environmental & Scientific Instruments Co.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=pyrogen-testing-market?ram (Purchase 2 or more Repots and get 50% Discount)

Market Dynamics and Growth Drivers:

-Increasing demand in the pharmaceutical and biotechnology sectors for ensuring the safety and efficacy of injectable drugs, biologics, and medical devices, driven by the rising prevalence of chronic diseases and new drug approvals.

-Stringent regulatory requirements and compliance standards globally for endotoxin and pyrogen testing to prevent harmful fever-inducing contaminants, which drive market adoption of advanced testing technologies.

-Growing investments in research and development and expanding production of biologics, vaccines, and sterile injectables fuel the need for more comprehensive pyrogen testing.

-Rising awareness about product safety and quality in emerging markets, along with the adoption of alternative in-vitro testing methods that reduce animal testing, supports sustained market growth worldwide.

Research Process:

Both primary and secondary data sources have been used in the Global Pyrogen Testing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Key Segments:

➥ By Product & Service: Assays, Kits, Reagents, Instruments, Services, Others

➥ By Test Type: LAL Tests, Rabbit Pyrogen Test, Monocyte Activation Test, Others

➥ By End-User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Others

Regional Analysis for Pyrogen Testing Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Contact Us -

Company Name: DataM Intelligence

Contact Person: Sai Kiran

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.